I. V. Kravchuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
I. V. Kravchuk has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
G. D. Telegeev
Institute of Molecular Biology and Genetics, NAS of Ukraine
2 shared publications- Alla Mironenko
State Institution Kyiv City Center for Diseases Control and Prevention for the Ministry of Health of Ukraine, 03190 Kyiv, Ukraine
1 shared publication - Andriy Goy
Joint Stock Company «Farmak», 04080 Kyiv, Ukraine
1 shared publication D. S. Gurianov
Institute of Molecular Biology and Genetics, NAS of Ukraine
1 shared publicationH D Teleheiev
1 shared publication- Larysa Radchenko
Gromashevsky L. V. Institute of Epidemiology and Infection Diseases, NAMS of Ukraine
1 shared publication
Latest Publications
- Open Access
- 14 April 2025
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Biopolymers and Cell
- Vol. 41 (1) , 32-41
Primary insights into structure and structururally determined features of C2 domain of Bcr
PrImAry InSIGhTS InTo STrucTure AnD STrucTurAlly DeTermIneD FeATureS oF c2 DomAIn oF Bcr The investigation of the C2 domain of Bcr is critical for understanding the functions of normal Bcr protein and the processes in cancer involving the hybrid Bcr-Abl. Aim: This study aimed to estimate the structure and lipid-binding capacity of the C2 domain of Bcr. Methods: The secondary and tertiary structures were predicted using various bioinformatic tools. A DNA fragment encoding the C2 domain was introduced into the expression vector pET28 using sequence and ligation-independent cloning techniques. The purified recombinant C2 domain was used to obtain circular dichroism spectra and perform a lipid-binding assay. Results: The structure predictions indicate that the C2 domain of Bcr likely adopts a typical beta-sandwich structure with type II topology. The circular dichroism data on the purified recombinant C2 domain confirmed the expected predominance of beta-structures. Binding to eight phospholipids was identified. Conclusions: The recombinant C2 domain of Bcr has a structure comparable to other well-studied C2 domains. Binding to various lipids suggests a possible specific localization of the Bcr protein on different cellular membrane structures.
- 14 April 2025
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Biopolymers and Cell
- Vol. 41 (1) , 32-41
Open AccessPrimary insights into structure and structururally determined features of C2 domain of Bcr
PrImAry InSIGhTS InTo STrucTure AnD STrucTurAlly DeTermIneD FeATureS oF c2 DomAIn oF Bcr The investigation of the C2 domain of Bcr is critical for understanding the functions of normal Bcr protein and the processes in cancer involving the hybrid Bcr-Abl. Aim: This study aimed to estimate the structure and lipid-binding capacity of the C2 domain of Bcr. Methods: The secondary and tertiary structures were predicted using various bioinformatic tools. A DNA fragment encoding the C2 domain was introduced into the expression vector pET28 using sequence and ligation-independent cloning techniques. The purified recombinant C2 domain was used to obtain circular dichroism spectra and perform a lipid-binding assay. Results: The structure predictions indicate that the C2 domain of Bcr likely adopts a typical beta-sandwich structure with type II topology. The circular dichroism data on the purified recombinant C2 domain confirmed the expected predominance of beta-structures. Binding to eight phospholipids was identified. Conclusions: The recombinant C2 domain of Bcr has a structure comparable to other well-studied C2 domains. Binding to various lipids suggests a possible specific localization of the Bcr protein on different cellular membrane structures.
- Open Access
- 13 June 2024
- Published by MDPI AG in Microbiology Research
- Vol. 15 (2) , 994-1006
Etiology of Four Waves of the COVID-19 Pandemic in Ukraine according to the SARS-CoV-2 Virus Genome Sequencing Data: A Pilot Study
The COVID-19 pandemic in Ukraine, from March 2020 to June 2022, witnessed distinct waves, each characterized by an increase in cases and fatalities. Next-generation sequencing has been used to understand the impact of viral variants on the pandemic situation in Ukraine. We analyzed SARS-CoV-2 genome sequencing data to identify viral variants circulating during each wave. By integrating epidemiological information, we established associations between viral variants and disease spread. The adoption of next-generation sequencing for SARS-CoV-2 surveillance in Ukraine, despite limited resources, yielded adequate and trustworthy results, reflecting the pandemic situation. After the Russian military invasion of Ukraine in February 2022, a large number of refugees crossed the border with neighboring countries. Mutation analysis on sequencing data from Ukraine and Poland was used to estimate the exchange of SARS-CoV-2 variants between the countries during this period. Omicron subvariants detected in both countries were similar. The analysis of SARS-CoV-2 sequences from Poland and Ukraine revealed shared nucleotide mutations that can be used to identify the directions of spreading.
- 13 June 2024
- Published by MDPI AG in Microbiology Research
- Vol. 15 (2) , 994-1006
Open AccessEtiology of Four Waves of the COVID-19 Pandemic in Ukraine according to the SARS-CoV-2 Virus Genome Sequencing Data: A Pilot Study
The COVID-19 pandemic in Ukraine, from March 2020 to June 2022, witnessed distinct waves, each characterized by an increase in cases and fatalities. Next-generation sequencing has been used to understand the impact of viral variants on the pandemic situation in Ukraine. We analyzed SARS-CoV-2 genome sequencing data to identify viral variants circulating during each wave. By integrating epidemiological information, we established associations between viral variants and disease spread. The adoption of next-generation sequencing for SARS-CoV-2 surveillance in Ukraine, despite limited resources, yielded adequate and trustworthy results, reflecting the pandemic situation. After the Russian military invasion of Ukraine in February 2022, a large number of refugees crossed the border with neighboring countries. Mutation analysis on sequencing data from Ukraine and Poland was used to estimate the exchange of SARS-CoV-2 variants between the countries during this period. Omicron subvariants detected in both countries were similar. The analysis of SARS-CoV-2 sequences from Poland and Ukraine revealed shared nucleotide mutations that can be used to identify the directions of spreading.
- 1 January 2020
- Published by Allerton Press in Cytology and Genetics
- Vol. 54 (1) , 48-54
Interaction of Bcl-Abl Oncoprotein with the Glg1 Protein in K562 Cells: its Role in the Pathogenesis of Chronic Myeloid Leukemia
Chronic Myeloid Leukemia (CML) is a clonal myeloproliferative disease characterized by the occurrence of the Bcr-Abl fusion oncoprotein, which resulted fro
- 1 January 2020
- Published by Allerton Press in Cytology and Genetics
- Vol. 54 (1) , 48-54
Interaction of Bcl-Abl Oncoprotein with the Glg1 Protein in K562 Cells: its Role in the Pathogenesis of Chronic Myeloid Leukemia
Chronic Myeloid Leukemia (CML) is a clonal myeloproliferative disease characterized by the occurrence of the Bcr-Abl fusion oncoprotein, which resulted fro
- 13 February 2007
- Vol. 78 (5) , 5-15
[Role of Ku protein in normal and cancer cells].
Ku protein is a multifunctional heterodimer of eukaryotes that consists of two subunits: Ku70 and Ku80. It plays a critical role in the regulation of many cellular processes such as: non-homologous end-joining, V(D)J-recombination of immunoglobulin genes and genes of T-cellular receptors, transcription regulation, DNA replication. Now the existence of relation between Ku protein functioning and processes that lead to transformation of normal cells into cancerous ones is determined, in Ph-positive leukemias and multiple myelomas, in particular. Nevertheless, the machinery of this processes is not still completely understood and needs further researches.
- 13 February 2007
- Vol. 78 (5) , 5-15
[Role of Ku protein in normal and cancer cells].
Ku protein is a multifunctional heterodimer of eukaryotes that consists of two subunits: Ku70 and Ku80. It plays a critical role in the regulation of many cellular processes such as: non-homologous end-joining, V(D)J-recombination of immunoglobulin genes and genes of T-cellular receptors, transcription regulation, DNA replication. Now the existence of relation between Ku protein functioning and processes that lead to transformation of normal cells into cancerous ones is determined, in Ph-positive leukemias and multiple myelomas, in particular. Nevertheless, the machinery of this processes is not still completely understood and needs further researches.